Dr. Michael Attanasio, D.O

NPI: 1174593958
Total Payments
$263,805
2024 Payments
$25,238
Companies
73
Transactions
1,982
Medicare Patients
6,351
Medicare Billing
$711,176

Payment Breakdown by Category

Other$150,495 (57.0%)
Consulting$62,410 (23.7%)
Food & Beverage$34,351 (13.0%)
Travel$16,257 (6.2%)
Education$292.56 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $150,495 100 57.0%
Consulting Fee $62,410 30 23.7%
Food and Beverage $34,351 1,779 13.0%
Travel and Lodging $16,257 60 6.2%
Education $292.56 13 0.1%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $145,440 277 $0 (2024)
Amgen Inc. $59,184 145 $0 (2024)
ABBVIE INC. $18,449 202 $0 (2024)
Allergan, Inc. $12,738 66 $0 (2022)
AstraZeneca Pharmaceuticals LP $3,715 129 $0 (2024)
Novo Nordisk Inc $3,171 185 $0 (2024)
Takeda Pharmaceuticals America, Inc. $3,066 7 $0 (2017)
Eli Lilly and Company $2,250 1 $0 (2020)
GlaxoSmithKline, LLC. $1,940 111 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,750 98 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $25,238 258 Amgen Inc. ($12,316)
2023 $62,236 348 Amgen Inc. ($30,898)
2022 $42,402 303 Janssen Pharmaceuticals, Inc ($21,318)
2021 $29,384 216 Janssen Pharmaceuticals, Inc ($19,617)
2020 $22,474 206 Janssen Pharmaceuticals, Inc ($11,687)
2019 $14,101 188 Janssen Pharmaceuticals, Inc ($11,027)
2018 $32,535 237 Janssen Pharmaceuticals, Inc ($24,097)
2017 $35,435 226 Janssen Pharmaceuticals, Inc ($29,830)

All Payment Transactions

1,982 individual payment records from CMS Open Payments — Page 80 of 80

Date Company Product Nature Form Amount Type
01/22/2017 Lilly USA, LLC TRULICITY (Drug), BASAGLAR Food and Beverage In-kind items and services $17.81 General
Category: Diabetes
01/19/2017 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $15.20 General
Category: Hypertriglyceridemia
01/16/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $18.11 General
Category: Cardiovascular & Metabolism
01/10/2017 AstraZeneca Pharmaceuticals LP BEVESPI AEROSPHERE (Drug) Food and Beverage In-kind items and services $18.39 General
Category: Respiratory
01/10/2017 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $11.71 General
Category: Hypertriglyceridemia
01/09/2017 Lilly USA, LLC TRULICITY (Drug), BASAGLAR Food and Beverage In-kind items and services $15.63 General
Category: Diabetes
01/05/2017 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $18.70 General
Category: Cardiology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 1,238 2,124 $281,405 $103,488
2022 12 1,568 2,729 $385,415 $128,719
2021 13 1,832 3,628 $461,360 $277,409
2020 21 1,713 3,094 $384,335 $201,560
Total Patients
6,351
Total Services
11,575
Medicare Billing
$711,176
Procedure Codes
57

All Medicare Procedures & Services

57 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 169 739 $88,680 $44,956 50.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 216 424 $86,920 $20,787 23.9%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 74 127 $18,415 $10,874 59.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 115 166 $24,070 $7,461 31.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 186 186 $37,400 $6,149 16.4%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 214 214 $5,355 $4,180 78.1%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 208 208 $6,240 $4,063 65.1%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 14 16 $4,000 $2,425 60.6%
99496 Transitional care management services for problem of high complexity Office 2023 15 16 $5,600 $1,444 25.8%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 15 15 $3,750 $1,002 26.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 12 13 $975.00 $147.00 15.1%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 163 668 $80,160 $38,176 47.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 310 729 $148,685 $37,059 24.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 208 416 $60,250 $19,805 32.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 248 248 $49,600 $8,353 16.8%
99309 Follow-up nursing facility visit per day, typically 25 minutes Facility 2022 53 76 $11,020 $5,692 51.7%
G0444 Annual depression screening, 15 minutes Office 2022 265 265 $7,950 $5,198 65.4%
G0442 Annual alcohol misuse screening, 15 minutes Office 2022 231 231 $5,775 $4,619 80.0%
99496 Transitional care management services for problem of high complexity Office 2022 22 27 $9,450 $3,869 40.9%
99306 Initial nursing facility visit per day, typically 45 minutes Facility 2022 27 27 $6,750 $3,699 54.8%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 13 13 $3,250 $1,480 45.5%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2022 14 14 $1,400 $585.57 41.8%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 14 15 $1,125 $183.32 16.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 342 997 $165,300 $99,149 60.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 278 698 $76,975 $51,664 67.1%

About Dr. Michael Attanasio, D.O

Dr. Michael Attanasio, D.O is a Family Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174593958.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Attanasio, D.O has received a total of $263,805 in payments from pharmaceutical and medical device companies, with $25,238 received in 2024. These payments were reported across 1,982 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($150,495).

As a Medicare-enrolled provider, Attanasio has provided services to 6,351 Medicare beneficiaries, totaling 11,575 services with total Medicare billing of $711,176. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Family Medicine
  • Location Philadelphia, PA
  • Active Since 01/25/2006
  • Last Updated 12/27/2016
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1174593958

Products in Payments

  • XARELTO (Drug) $88,517
  • Repatha (Biological) $58,259
  • INVOKANA (Drug) $56,923
  • UBRELVY (Drug) $18,645
  • VRAYLAR (Drug) $6,981
  • QULIPTA (Drug) $4,968
  • JARDIANCE (Drug) $3,377
  • Trintellix (Drug) $3,177
  • Ozempic (Drug) $1,610
  • TRELEGY ELLIPTA (Drug) $1,426
  • FARXIGA (Drug) $1,390
  • TRULICITY (Drug) $915.48
  • Kerendia (Drug) $860.21
  • BREZTRI (Drug) $851.93
  • ENTRESTO (Drug) $760.82
  • Vascepa (Drug) $712.58
  • XIFAXAN (Drug) $637.74
  • Otezla (Drug) $530.23
  • JANUVIA (Drug) $454.48
  • SYMBICORT (Drug) $430.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Philadelphia